The incidence of cardiovascular disease differs significantly between men and women, in
part because of differences in risk factors and hormones. 1 The incidence of atherosclerotic …

Aortocoronary saphenous vein graft disease, with its increasing clinical sequelae, presents
an important and unresolved dilemma in cardiological practice. During the 1st month after …

Context.—Observational studies have found lower rates of coronary heart disease (CHD) in
postmenopausal women who take estrogen than in women who do not, but this potential …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies in the management or prevention of disease …

ContextHormone replacement therapy (HRT) and antioxidant vitamins are widely used for
secondary prevention in postmenopausal women with coronary disease, but no clinical trials …

Summary...... 1277 1.3. 4. Comparison With Percutaneous Techniques...... 1277 1.3. 4.1.
Overview of Randomized Trials...... 1278 1.3. 4.2. Results of Randomized Trials...... 1280 1.3 …

Cardiovascular risk is poorly managed in women, especially during the menopausal
transition when susceptibility to cardiovascular events increases. Clear gender differences …

OBJECTIVE: To assess the possible benefit of hormone replacement therapy (HRT) in the
secondary prevention of ischaemic heart disease. DESIGN: A prospective randomised trial …

Postmenopausal hormone therapy (PMHT) is used for the relief of menopausal symptoms,
but the dosage has varied greatly throughout its existence. By the end of the 1990s, PMHT …

This systematic review assesses the effect of menopausal hormone therapy (MHT) on
cardiovascular outcomes and risk factors in postmenopausal women with cardiovascular …